Zoono Group Limited (AU:ZNO) has released an update.
Zoono Group Limited, a global biotech company, announces a non-renounceable entitlement offer to raise approximately $2.88 million by offering new shares, with the potential to issue over 106 million additional shares if fully subscribed. The offer, which is partially underwritten, aims to allow shareholders to retain their percentage ownership and is not expected to significantly alter company control. Zoono specializes in long-lasting, eco-friendly antimicrobial products, with a presence in various international markets.
For further insights into AU:ZNO stock, check out TipRanks’ Stock Analysis page.
